These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6516213)

  • 21. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H3N2) virus.
    Teodorovici G; Ivan A; Vieriu V; Duman F; Stenţer M; Frunzăreanu N; Petrescu A; Mihail A; Cajal N
    Virologie; 1984; 35(1):39-41. PubMed ID: 6710860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing the safety and effectiveness of oral administration of a live influenza vaccine.
    Aleksandrova GI; Smorodintsev AA; Beljaeva NM; Vasil'ev BJ; Geft RA; Panteleev VG; Sejfer MA; Selivanov AA
    Bull World Health Organ; 1970; 42(3):429-36. PubMed ID: 5310592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 27. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine].
    Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP
    Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problems of specific secretory antiviral immunity].
    Shvartsman IaS
    Usp Sovrem Biol; 1976; 81(3):429-44. PubMed ID: 788388
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H1N1) virus.
    Teodorovici G; Ivan A; Petrescu A; Mihail A; Cajal N
    Virologie; 1982; 33(4):279-82. PubMed ID: 7164342
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
    Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B
    Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.
    Wu J; Liu SZ; Dong SS; Dong XP; Zhang WL; Lu M; Li CG; Zhou JC; Fang HH; Liu Y; Liu LY; Qiu YZ; Gao Q; Zhang XM; Chen JT; Zhong X; Yin WD; Feng ZJ
    Vaccine; 2010 Aug; 28(38):6221-7. PubMed ID: 20638454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-influenza vaccination in children].
    Battistini A; Ollari R; Dodi L
    Pediatr Med Chir; 1985; 7(3):369-74. PubMed ID: 3915545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal immunity and nasal influenza vaccination.
    Rose MA; Zielen S; Baumann U
    Expert Rev Vaccines; 2012 May; 11(5):595-607. PubMed ID: 22827245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?].
    Moraga Llop FA; Campins Martí M
    An Esp Pediatr; 2000 Oct; 53(4):299-304. PubMed ID: 11523509
    [No Abstract]   [Full Text] [Related]  

  • 35. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccination by nasal route in a semi-closed community.
    Steiner N; Petrescu A; Teodosiu O; Mihail A; Mihăilescu M; Steiner G; Berca C; Călina A; Soare C
    Virologie; 1980; 31(2):117-20. PubMed ID: 7405010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.